Despite challenges like high production costs and uneven regulations, the region is set to become a hub for cutting-edge ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Despite challenges like high costs and regulatory complexities, Europe's vibrant research ecosystem and EMA's supportive ATMP ...

Bio-Gene Technology Ltd. ( ($AU:BGT) ) has shared an announcement. Bio-Gene Technology Limited reported significant progress in Q1 FY26, including ...

However, as part of the deal, Avidity will first spin off its "early stage precision cardiology programs," for which "Avidity stockholders will also receive consideration for the separation of the ...

Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...

Speaking about the Conference, Arun Kedia, Managing Director, VAV Lipids, said, "We are delighted to extend our support to IIT Bombay, an institution known for its academic excellence and innovation.

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

A new scalable technique enables the generation of human kidney organoids by integrating them into perfused pig kidneys.

Harvard’s Berkman Klein Center for Internet & Society welcomes applications for its 2026 and 2026-2027 fellowships.

Principal Technologies Inc. (the "Company" or "Principal") announces that it has entered into a research and development agreement with the University of Oxford ("Oxford") to develop and test the ...